Press MF - Search Results

1

Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer.

Garon EB, Siegfried JM, Stabile LP, Young PA, Marquez-Garban DC, Park DJ, Patel R, Hu EH, Sadeghi S, Parikh RJ, Reckamp KL, Adams B, Elashoff RM, Elashoff D, Grogan T, Wang HJ, Dacic S, Brennan M, Valdes Y, Davenport S, Dubinett SM, Press MF, Slamon DJ, Pietras RJ. Garon EB, et al. Among authors: press mf. Lung Cancer. 2018 Sep;123:91-98. doi: 10.1016/j.lungcan.2018.06.013. Epub 2018 Jun 22. Lung Cancer. 2018. PMID: 30089602 Free PMC article. Clinical Trial.

2

Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

Press MF, Cordon-Cardo C, Slamon DJ. Press MF, et al. Oncogene. 1990 Jul;5(7):953-62. Oncogene. 1990. PMID: 1973830

3

HER-2/neu oncogene amplification and expression in breast and ovarian cancers.

Press MF, Jones LA, Godolphin W, Edwards CL, Slamon DJ. Press MF, et al. Prog Clin Biol Res. 1990;354A:209-21. Prog Clin Biol Res. 1990. PMID: 1978943 Review. No abstract available.

4

Subnuclear localization of the trans-activating protein of human T-cell leukemia virus type I.

Slamon DJ, Boyle WJ, Keith DE, Press MF, Golde DW, Souza LM. Slamon DJ, et al. Among authors: press mf. J Virol. 1988 Mar;62(3):680-6. doi: 10.1128/JVI.62.3.680-686.1988. J Virol. 1988. PMID: 2828664 Free PMC article.

5

Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group.

Levin WJ, Press MF, Gaynor RB, Sukhatme VP, Boone TC, Reissmann PT, Figlin RA, Holmes EC, Souza LM, Slamon DJ. Levin WJ, et al. Among authors: press mf. Oncogene. 1995 Oct 5;11(7):1261-9. Oncogene. 1995. PMID: 7478546

6

Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.

Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG, et al. Press MF, et al. Cancer Res. 1994 Nov 1;54(21):5675-82. Cancer Res. 1994. PMID: 7522962

7

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

Press MF, Hung G, Godolphin W, Slamon DJ. Press MF, et al. Cancer Res. 1994 May 15;54(10):2771-7. Cancer Res. 1994. PMID: 7909495

8

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.

Pauletti G, Godolphin W, Press MF, Slamon DJ. Pauletti G, et al. Among authors: press mf. Oncogene. 1996 Jul 4;13(1):63-72. Oncogene. 1996. PMID: 8700555

9

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR, Flom KJ. Press MF, et al. J Clin Oncol. 1997 Aug;15(8):2894-904. doi: 10.1200/JCO.1997.15.8.2894. J Clin Oncol. 1997. PMID: 9256133

10

Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas.

Wilson CA, Ramos L, Villaseñor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ, Slamon DJ. Wilson CA, et al. Among authors: press mf. Nat Genet. 1999 Feb;21(2):236-40. doi: 10.1038/6029. Nat Genet. 1999. PMID: 9988281

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page